BANGKOK CHAIN HOSPITAL PUBLIC COMPANY LIMITEDSET: BCH🇹🇭 TH

MD&A · 2025

Overview of Operations

Overview of Operations

In 2025, The Company and its affiliated hospitals reported a total revenue of 12,025.4 million baht, representing an increase of 1.6% yoy. The growth was primarily driven by a 6.7% increase in revenue from Social Security Scheme patients, supported by a 0.6% increase in the average number of registered insured persons, as well as service improvements and upgrades at key hospitals, including Kasemrad Hospital Bangkae, Kasemrad Hospital Prachachuen, and Kasemrad Hospital Pathumthani, which enhanced convenience and reduced waiting times for insured patients. Additional support came from reimbursement for high-complexity cases (RW>2) at a rate of 12,000 baht per RW throughout 2025. Furthermore, revenue growth was supported by services such as sleep apnea diagnostics, mobile dental services, referrals from non-affiliated hospitals, and services provided by Kasemrad Ari Radiation Oncology Clinic.

The Company reported EBITDA of 2,881.4 million baht, an increase of 6.4% yoy, with an EBITDA margin of 24.0%, improving from the previous year. Net profit attributable to the Company totaled 1,316.4 million baht, representing an increase of 2.7% yoy, with a net profit margin of 10.9%, remaining relatively stable compared to the previous year.

Operating Results & Financial Condition

Operating Results & Profitability

For the overall performance of the Company and affiliated hospitals in 2025, revenue from hospital operations of 11,913.0 million baht, representing an increase of 1.6 percent yoy. Revenue from general patients totaled 7,763.8 million baht, which decline by (2.1) percent yoy. The details are as follows:

  • Revenue from general OPD patients amounted to 4,368.8 million baht, a decrease of (1.3) percent yoy, due to a slowdown in international patients. Specifically, Cambodian patient volumes at Kasemrad International Hospital Aranyaprathet and Kasemrad Ramkhamhaeng were impacted by the Thai-Cambodian border closure during the second half of 2025. Conversely, Thai outpatient revenue continued to grow, driven by specialized medical centers such as Radiotherapy, Surgery, and Hemodialysis centers. Growth was further supported by increased patient volumes at new and renovated facilities, including Kasemrad International Vientiane, Kasemrad Prachinburi, and Kasemrad Pathum Thani. Additionally, the expansion of Kasemrad Plastic Surgery (KPS) and comprehensive body contouring services significantly contributed to outpatient revenue growth.

  • Revenue from general IPD patients amounted to 3,395.0 million baht, a decrease of (3.1) percent yoy, due to slowdown in international patients particularly Cambodia as well as the Kuwaiti government has revised policy on overseas medical referrals. Furthermore, certain service areas underwent renovations during the first half of 2025, including Kasemrad Hospital Bangkae and Kasemrad Hospital Pathumthani. Nevertheless, Thai inpatient revenue continued to grow through specialized centers across the network such as the Comprehensive Heart Center and the Obstetrics-Gynecology Center.

  • Revenue from social security patient amounted to 4,149.0 million baht, 6.7 percent rise yoy. In 2025, the average number of registered persons in the Kasemrad network reached 1,027,813, representing a 0.6 percent increase yoy. This growth resulted from online promotional activities and collaborations with private sectors, industrial factories and local communities. Additionally, proactive services were implemented across all Kasemrad branches, including health check-ups, dental services, and mobile vaccination units. Additionally, Social Security revenue grew from medical service fees for high-complexity cases (RW > 2) at a rate of 12,000 baht per RW throughout 2025. Further growth was driven by patient referral services and sleep apnea diagnostics, for which the hospital continues to provide ongoing patient follow-up throughout 2026.

The Company reported an operating profit of 1,814.7 million baht for 2025, representing an increase 6.1 percent yoy. Earnings before interest, tax, depreciation, and amortization (EBITDA) amounted to 2,881.4 million baht, rise 6.4 percent yoy, with an EBITDA margin of 24.0 percent. Net profit attributable to the Company was 1,316.4 million baht, representing an increase of 2.7 percent yoy with a net profit margin attributable to the Company’s shareholders of 10.9 percent.

Liquidity & Capital Adequacy

As of 31 December 2025, there was a net increase of 245.7 million baht

The net cash at the beginning of the period on 1 January 2025 was 1,345.4 million baht. The operational activities contributed to the net cash at the end of the period on 31 December 2025, amounted to 1,591.1 million baht. For detailed information on the cash flows for each activity are as follows:

Net Cash flow from operating activities amounted to 2,681.7 million baht, driven by operating profits from the network hospitals and cash collections from the Social Security Office and trade receivables. Driven by operating profits from the affiliated hospitals and reimbursements from the Social Security Office. Furthermore, the Company recorded a cash inflow of 246 million baht from the settlement of accounts receivable related to medical services provided to Kuwaiti patients through the Kuwait Embassy.

Net cash flow used in investment activities amounted to (1,171.6) million baht, primarily directed toward enhancing service capabilities through building renovations and acquisition of advanced medical equipment across the affiliated hospitals. Furthermore, the Company continued its capital expenditure for construction of two new hospitals: Kasemrad Hospital Suvarnabhumi and Kasemrad Hospital Rayong. The Company also allocated funds for liquidity management through investments in short-term fixed income funds.

Net cash flow used in financing activities amounted to (1,316.3) million baht, primarily attributed to dividend payments to shareholders and the repayment of loans from financial institutions.

Asset Management Capability

As of 31 December 2025, the Company has total Assets totaled of 17,486.1 million baht, an increase of 0.6 percent comparing to previous year, this growth was primarily driven by an increase in cash and cash equivalents. Furthermore, other current financial assets increased, following investments in short-term fixed income funds by Saraburi Watchakit Company Limited.

Total Liabilities totaled of 3,279.2 million baht, a decrease of (2.0) percent comparing to previous year, primarily due to the reduction in loans from financial institutions.

Total Shareholders’ Equity totaled of 14,206.8 million baht, increased 1.3 percent comparing to previous year, due to the Company’s retained earnings from operations.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

No

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

Throughout the year 2026, the trend of proactive and preventive healthcare behavior is expected to maintain its continuous growth momentum. Simultaneously, Thailand’s increasingly clear political stability serves as a pivotal factor in bolstering the confidence of both domestic and international investors. This is particularly evident in the tourism sector, which is poised for a significant resurgence, creating a substantial positive impact on the private hospital industry through the expansion of Medical Tourism. Furthermore, the adjustment of the Social Security Office’s wage ceiling and contribution rates, effective January 1, 2026, will enhance the Social Security Fund’s long-term stability. This fiscal strengthening enables the fund to revise benefit disbursements for insured members to more accurately reflect the actual rising operating costs of hospitals.

However, amidst emerging opportunities and changes, the hospital industry must swiftly adapt strategies to keep pace with evolving patient behaviors and market conditions. Specifically, alignment with new insurance policies transitioning from lump-sum coverage to Co-payment models is crucial. Simultaneously, accelerating technology and service innovation remains a key competitive factor to meet patient demands for convenience, value, and consistently satisfying treatment experiences.

To adapt, the Company remains committed to providing standardized quality medical care and enhancing hospital capabilities through comprehensive service technology upgrades. This covers diagnosis, treatment, rehabilitation, and referrals, alongside continuous personnel development. Furthermore, the Company plans to expand new hospitals to ensure sustainable growth, following the strategic operational plans detailed below.


1. Commitment to Enhancing Service Capabilities for All Patient Segments

The Company has strategically integrated state-of-the-art medical innovations to ensure patients receive the highest level of treatment efficiency, especially for highly complex conditions. This includes the implementation of advanced rehabilitation robots designed to restore joint and muscle functions for post-treatment recovery and elderly care, exclusively provided through the Robotic Rehabilitation Center at World Medical Hospital. Furthermore, the installation of advanced MRI 3-Tesla technology at Kasemrad International Hospital Rattanatibeth significantly enhances diagnostic and therapeutic capabilities by providing superior precision, clarity, and speed. Such technological advancements are crucial for increasing survival rates and ensuring effective treatment outcomes for high-risk diseases, particularly those involving neurological and cardiovascular systems. Consequently, the hospital is well-positioned to serve as a primary referral hub for both affiliated network hospitals and local medical facilities.


2. Eeading Tertiary Care Provider with the Exclusive JCI Accreditation in Lao PDR

Kasemrad International Hospital Vientiane, a 110-bed facility located in the capital of Lao PDR, has achieved remarkable success in providing advanced diagnostics and specialized treatments for high-complexity diseases. This is accomplished through its highly specialized Centers, which offer life-saving procedures such as open-heart surgery and neurosurgery. Furthermore, the hospital reached a historic milestone in September 2025 by becoming the first healthcare institution in Lao PDR to receive the prestigious Joint Commission International (JCI) accreditation. This global recognition has significantly bolstered confidence among local Lao citizens, expatriates living in the region, and international tourists alike.

In 2025, the hospital reported a total revenue of 397.8 million baht, representing a 13.0 percent increase yoy. The EBITDA was 65.8 million baht, marking a growth of 98.0 percent yoy. Looking ahead to 2026, the hospital remains steadfast in its commitment to launching new specialized medical centers to meet patient demands while simultaneously elevating the public healthcare standards of Lao PDR. Planned expansions include an Aesthetic Center, Breast Cancer Center and Radiation Oncology Center. Moreover, the hospital intends to strengthen its market presence by expanding its patient base and establishing a robust referral network with local clinics and hospitals. This strategy, combined with continuous upgrades of advanced medical equipment, will drive sustainable growth for high-demand units such as the Obstetrics and Gynecology Center, Physical Therapy Center, Stroke Center, and the Comprehensive Heart Center.

3. Developing an integrated ecosystem to drive Smart Hospital transformation.

The Company has strategically developed a comprehensive mobile application to facilitate a seamless patient journey, covering everything from appointment scheduling and on-site services to real-time medical result reporting. This digital transformation effectively streamlines operational steps, minimizes waiting times, and mitigates potential human errors. Furthermore, the Company has pioneered an advanced electronic referral system (e-refer) specifically designed for cancer patients. This system serves as a centralized mechanism to systematically integrate treatment processes across our entire hospital network, encompassing diagnosis, treatment evaluation, and the final referral to the Kasemrad Ari Radiation Oncology Clinic. By ensuring medical practitioners can access patient data in advance, the system significantly reduces delays and risks associated with data fragmentation. Additionally, this digital initiative drastically reduces the reliance on physical medical documents, leading to a measurable reduction in resource consumption, energy usage, and the overall environmental impact of our healthcare delivery processes.

4. Elevating service care through renovations and new greenfield hospital expansions

The Company is steadfast in its commitment to continuously elevating the quality of medical services through the comprehensive renovation and enhancement of hospital environments, both internal and external. By upgrading medical technology and expanding specialized medical centers, we aim to deliver superior patient experiences and address the evolving needs of our patients with precision and care. Our various hospital renovation projects are progressing steadily in accordance with the Company’s strategic timeline, with key details as follows:

  • Kasemrad Hospital Bangkae is currently undergoing a major renovation of its service areas dedicated to Social Security Scheme patients. The project involves upgrading the Medical Center on the 1st and 2nd floors, which encompasses the Outpatient Department (PD), consultation rooms, as well as the Dental, Surgical, and Ear, Nose and Throat (ENT) Centers. The renovation also extends to the pharmacy, patient waiting areas, and the parking facilities on the 3rd to 5th floors. These enhancements are expected to be fully completed and ready for service by March 2026.

1

1

1

  • Kasemrad Hospital Maesai has commenced the construction of new building to accommodate the growing demand from both Thai and international patients. This new facility will feature comprehensive service areas, including a General Medical Department, Emergency Department, Pediatric Center, Dental Center and inpatient rooms. Construction began in April 2025 and is progressing through the installation of building systems and interior architectural works. The new facility is expected to officially commence operations in Q2/2026.

    1

  • Kasemrad Hospital Ramkhamhaeng is set to commence a new additional building expansion. This project is designed to increase capacity for both general patients and those patient under the social security scheme. The new facility will feature expanded outpatient (PD) and inpatient (IPD) departments, along with a dedicated parking structure. Construction is slated to begin within 2026, with the official opening expected in 2027.

1

The Company currently has two new hospitals under construction, with details as follows:

  • Kasemrad Hospital Suvarnabhumi, located in Samut Prakan Province, is 270 licensed beds with a total investment budget of approximately 1,650 million baht, including the 25-rai land acquisition. The project situated near the Bang Phli Industrial Estate and dense residential areas, the hospital aims to serve both general patients and those under the Social Security Scheme. Construction is currently underway, focusing on the foundation and floor structures. The hospital is slated to officially commence operations in Q1/2028.

1

1

1

1

1

  • Kasemrad Hospital Rayong, located in Rayong Province, is a 268 licensed beds registered facility with a total investment budget of approximately 1,480 million baht, inclusive of the 30-rai land acquisition. The hospital strategically targets both general patients and those under the Social Security Scheme, leveraging Rayong’s position as a major hub for numerous industrial estates. Furthermore, its location within the Eastern Economic Corridor (EEC) entitles the Company to significant tax incentives and other strategic privileges. Currently, construction is progressing through the third and fourth floor structures. The hospital is slated to officially commence operations in Q4/2027.

Contents